IQVIA Holdings vs Revolution Medicines
IQVIA Holdings (IQV), health care, and Revolution Medicines (RVMD), health care, side by side on market value, valuation, margins, balance sheet and price change. Higher and lower are marked; neither is called better.
IQVIA Holdings is worth $42.5B on the stock market and Revolution Medicines $35.2B: IQVIA Holdings is valued at 21% more. Over the past year IQVIA Holdings's share price has moved +21.8% and Revolution Medicines's +136%.
Key facts
- IQVIA Holdings market value
- $42.5B
- Revolution Medicines market value
- $35.2B
- IQVIA Holdings P/E
- 32.2
- IQVIA Holdings revenue
- $16.3BFY to 2025-12-31
- Revolution Medicines revenue
- $0FY to 2025-12-31
- Superinvestors holding both
- 0
Market values as of .
| Measure | IQVIA Holdings | Revolution Medicines |
|---|---|---|
| Sector | Health Care | Health Care |
| Country | ||
| Fiscal year ends | 2025-12-31 | 2025-12-31 |
| Size | ||
| Market cap | $42.5Bhigher | $35.2Blower |
| Revenue | $16.3Bhigher | $0lower |
| Earnings | $1.4Bhigher | -$1.1Blower |
| Employees | 95,000higher | 883lower |
| Total assets | $29.9Bhigher | $2.4Blower |
| Valuation | ||
| P/E | 32.2 | — |
| P/S | 2.6 | — |
| P/B | 6.4lower | 14.7higher |
| Dividend yield | 0.00% | 0.00% |
| Profitability | ||
| Operating margin | 13.4% | — |
| Balance sheet | ||
| Net assets | $6.5Bhigher | $1.6Blower |
| Total liabilities | $23.3Bhigher | $723.2Mlower |
| Total debt | $15.7B | — |
| Cash on hand | $2Bhigher | $383.7Mlower |
| Price change | ||
| Today | -2.69%lower | -2.50%higher |
| 1 year | +21.8%lower | +136%higher |
Market value, P/E, P/B, dividend yield and price changes are from live quotes (Yahoo Finance; prices may be delayed 15 minutes or more). Revenue, earnings, operating margin and the balance-sheet figures are from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day. P/S sets today's market value against the latest fiscal year's revenue. “Higher” and “lower” compare the two numbers only; a higher P/E or more debt is not better. Dividend yield and P/B are shown only for companies based in the US. A dash means no figure is on file.
Which superinvestors hold them
From each tracked investor's latest 13F filing. A 13F lists long positions in US-listed shares at a quarter end, filed up to 45 days later.
Both (0)
None of the tracked investors.
IQVIA Holdings only (8)
- Eric Bannasch12.1%
- Andrew Wellington4.5%
- Anthony Bozza3.2%
- Bill Nygren3.1%
- Harry Burn2.8%
- Edgar Wachenheim1.8%
- Tom Gayner0.1%
- Charles Brandes (founder)0.1%
Revolution Medicines only (5)
- Andrew Spokes14.4%
- Julian and Felix Baker10.7%
- Stanley Druckenmiller1.7%
- Brandon Haley0.6%
- Louis Bacon0.5%
Percentages are each holding's share of that investor's reported portfolio. Who owns IQV · Who owns RVMD
More on IQVIA Holdings
Further comparisons
IQVIA Holdings against its closest peers
Revolution Medicines against its closest peers
Learn
Questions and answers
Which is bigger, IQVIA Holdings or Revolution Medicines?
By market value, IQVIA Holdings is the larger: $42.5B against $35.2B for Revolution Medicines. By revenue in its latest fiscal year, IQVIA Holdings is the larger: $16.3B against $0 for Revolution Medicines.
Which has the higher dividend yield?
Neither: both stand at 0.00%. Dividend yield is the last twelve months' dividends as a share of today's share price.
Which superinvestors own both IQVIA Holdings and Revolution Medicines?
None of the tracked superinvestors holds both in their latest 13F filing. 8 hold IQVIA Holdings and 5 hold Revolution Medicines.
Cite this page
Funkfolio, “IQVIA Holdings vs Revolution Medicines”, data as of 18 November 2026. https://funkfolio.com/compare/iqv-vs-rvmd
Underlying data: Yahoo Finance quotes; SEC annual reports collected 2026-11-12; 13F filings.